South San Francisco, CA May 2, 2016 LYONBIOPOLE Press Release 
Biotechnology Industry Organization (BIO) International Convention Booth 705, June 6th-9th, San Francisco, CA
Lyon, France –
LYONBIOPOLE, the organization dedicated to the life science cluster in French Auvergne-Rhône-Alpes Region, will unite twenty-five groups from the region at the 2016 edition of the BIO International Convention.
This French region is recognized as an international life science cluster. It’s a center for research and high-level education, making specialized talent easily available. LYONBIOPOLE further drives innovation with attractive infrastructure for business.
LYONBIOPOLE is the gateway to life science innovation in the Auvergne Rhône-Alpes Region. The group supports ambitious projects and companies to encourage technologies, products and services for personalized medicine that benefits the patient.
LYONBIOPOLE will bring together twenty-five strategic life science companies in the French Pavilion at the BIO International Convention. The LYONBIOPOLE booth will include:
Alaxia
VOXCAN
Alizé Pharma
Theranexus
CELLIPSE
ADOCIA
CapEval Pharma
elsalys biotech
MaaT Pharma
Prediction BioSciences
ImmunID
Neolys Diagnostics
LXRepair
Inovotion
CYTOO
TransCure bioServices SAS
genOway
EVEON
Flamel
Erytech
Enyo
Novasep
CEA LETI
ACCINOV
BIOASTER
To book an appointment and meet with LYONBIOPOLE and the organizations they are bringing to the BIO International Convention, please contact Dalyce Semko Suanez at (403)869-3259.
About Lyonbiopole
As a Bio Cluster, Lyonbiopole is the gateway to healthcare innovation in the Auvergne Rhône-Alpes Region. The cluster supports ambitious projects and companies in the health sector (infectious diseases, cancer, nutrition, metabolic diseases.). Their aim is to support innovative technologies, products and services for more personalized medicine that benefits the patient.
Lyonbiopole is involved in 4 strategic areas: human medicine; veterinary medicine; in vitro diagnostics; medical devices. Its missions are: 1) to promote the emergence of innovative R&D collaborative projects; 2) to support SME for strategic partnerships, access to private investors, expertise and training; 3) to foster SMB Internationalization and the cluster position at the EU and International levels; 4) to give access to high-level dedicated facilities.
Lyonbiopole received the “Gold Label” by ECEI in 2014. In 2015, Lyonbiopole represented 190 members: 5 world-class leaders including its founders (Sanofi Pasteur, bioMérieux, Merial, BD); 17 Research Centers including 3 Hospital University Centers; 168 SMEs.
More information: www.lyonbiopole.com
###
More on the Biotechnology Industry Organization (BIO) International Convention June 6th-9th, San Francisco, CA CLICK HERE